نتایج جستجو برای: boost vaccination

تعداد نتایج: 84560  

Journal: :Infection and immunity 2006
Liana Tsenova Ryhor Harbacheuski Andre L Moreira Evette Ellison Wilfried Dalemans Mark R Alderson Barun Mathema Steven G Reed Yasir A W Skeiky Gilla Kaplan

Using a rabbit model of tuberculous meningitis, we evaluated the protective efficacy of vaccination with the recombinant polyprotein Mtb72F, which is formulated in two alternative adjuvants, AS02A and AS01B, and compared this to vaccination with Mycobacterium bovis bacillus Calmette-Guérin (BCG) alone or as a BCG prime/Mtb72F-boost regimen. Vaccination with Mtb72F formulated in AS02A (Mtb72F+AS...

2013
Rachel Buglione-Corbett Kimberly Pouliot Robyn Marty-Roix Kim West Shixia Wang Egil Lien Shan Lu

In recent years, heterologous prime-boost vaccines have been demonstrated to be an effective strategy for generating protective immunity, consisting of both humoral and cell-mediated immune responses against a variety of pathogens including HIV-1. Previous reports of preclinical and clinical studies have shown the enhanced immunogenicity of viral vector or DNA vaccination followed by heterologo...

2008
Vaidya R. M. Nanal

This paper elaborates the Ayurvedic perspective on preventive medicine in children, with specific reference to vaccination. It explores alternative approaches to boost immunity in children.

2015
Sharon Sheehan Stephanie A. Harris Iman Satti David A. Hokey Veerabadran Dheenadhayalan Lisa Stockdale Zita-Rose Manjaly Thomas Alice Minhinnick Morven Wilkie Samantha Vermaak Joel Meyer Matthew K. O’Shea Maria Grazia Pau Isabella Versteege Macaya Douoguih Jenny Hendriks Jerald Sadoff Bernard Landry Paul Moss Helen McShane David Joseph Diemert

BACKGROUND MVA85A and AERAS-402 are two clinically advanced viral vectored TB vaccine candidates expressing Mycobacterium tuberculosis antigens designed to boost BCG-induced immunity. Clinical trials with candidate malaria vaccines have demonstrated that adenoviral vector based priming immunisation, followed by MVA vector boost, induced high levels of immunity. We present the safety and immunog...

2010
Scott A. Brown Sherri L. Surman Robert Sealy Bart G. Jones Karen S. Slobod Kristen Branum Timothy D. Lockey Nanna Howlett Pamela Freiden Patricia Flynn Julia L. Hurwitz

Currently, there are more than 30 million people infected with HIV-1 and thousands more are infected each day. Vaccination is the single most effective mechanism for prevention of viral disease, and after more than 25 years of research, one vaccine has shown somewhat encouraging results in an advanced clinical efficacy trial. A modified intent-to-treat analysis of trial results showed that infe...

Journal: :Journal of virology 2002
Jon D Reuter Beatriz E Vivas-Gonzalez Daniel Gomez Jean H Wilson Janet L Brandsma Heather L Greenstone John K Rose Anjeanette Roberts

Immunizations with live recombinant vesicular stomatitis viruses (rVSV) expressing foreign viral proteins have successfully protected animals from challenges with several heterologous viruses. We developed an rVSV expressing the major capsid protein (L1) of cottontail rabbit papillomavirus (CRPV) and tested the efficacy of protection following CRPV challenge. An rVSV expressing L1 of CRPV (VSV-...

2013
Anne Fournillier Lars Frelin Emilie Jacquier Gustaf Ahlén Anette Brass Estelle Gerossier Fredrik Holmström Kate E. Broderick Niranjan Y. Sardesai Jean-Yves Bonnefoy Geneviève Inchauspé Matti Sällberg

BACKGROUND We explored the concept of heterologous prime/boost vaccination using 2 therapeutic vaccines currently in clinical development aimed at treating chronically infected hepatitis C virus (HCV) patients: prime with a DNA-based vaccine expressing HCV genotype 1a NS3/4A proteins (ChronVac-C) and boost with a modified vaccinia virus Ankara vaccine expressing genotype 1b NS3/4/5B proteins (M...

2011
Hang Xie Xianghong Jing Xing Li Zhengshi Lin Ewan Plant Olga Zoueva Hong Yang Zhiping Ye

The campaign of 2009-2010 Northern Hemisphere seasonal vaccination was concurrent with the 2009 H1N1 pandemic. Using a hemagglutination inhibition (HAI) assay, we evaluated the immunogenicity and cross-reactivity of 2009-2010 inactivated trivalent influenza vaccine (TIV) in US adult and elderly populations. Vaccination of TIV resulted in a robust boost on the antibody response of all subjects t...

Journal: :Vaccine 2009
Ariane Rodríguez Ratna Mintardjo Dennis Tax Gert Gillissen Jerome Custers Maria Grazia Pau Jaco Klap Sampa Santra Harikrishnan Balachandran Norman L Letvin Jaap Goudsmit Katarina Radosević

A vaccine that elicits both specific antibodies and IFN-gamma-producing T cells is required to protect against pre-erythrocytic malaria. Among the most promising approaches to induce such complex immunity are heterologous prime-boost vaccination regimens, in particular ones containing live viral vector. We have demonstrated previously that adenovectors serotype 35 (Ads35) encoding the circumspo...

2017
Giovanni Loris Alborali Jessica Ruggeri Michele Pesciaroli Nicola Martinelli Barbara Chirullo Serena Ammendola Andrea Battistoni Maria Cristina Ossiprandi Attilio Corradi Paolo Pasquali

BACKGROUND Salmonella enterica serovar Choleraesuis (S. Choleraesuis) infection causes a systemic disease in pigs. Vaccination could represent a solution to reduce prevalence in farms. In this study, we aimed to assess the efficacy of an attenuated strain of Salmonella enterica serovar Typhimurium (S. Typhimurium ΔznuABC) against S. Choleraesuis infection. The vaccination protocol combined prim...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید